Michael H. Mulroy - Director at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
LCTX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael H. Mulroy since 06 Mar 2025

Holdings reported by Michael H. Mulroy for Lineage Cell Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 298,555 $168,982 $0.5660 22 Nov 2024 Direct
Stock Option (Right to Buy) 75,000 01 Jul 2025 Direct Common Shares

Transactions reported by Michael H. Mulroy for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.